Heartseed
ID: 7683241Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
2
Funding Rounds
$63.0m
Money raised
Recent Funding Rounds
Overview
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
- Websites:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Heartseed has raised a total of $63m in funding over 2 rounds.
Key Insights:
- Heartseed Series C round, June 2021: $37m
- Heartseed Series B round, November 2019: $26m
Industries
Heartseed is active in the following industries: